Clinical Trials Logo

Rupture clinical trials

View clinical trials related to Rupture.

Filter by:

NCT ID: NCT03408379 Active, not recruiting - Clinical trials for Intracranial Aneurysms

Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN

PLAQRAN
Start date: December 20, 2017
Phase:
Study type: Observational

Sub arachnoid hemorrhage consecutive to intracranial aneurysm rupture is a devastating disease. Predictors of intracranial aneurysm rupture are limited and focus mainly on size and location. Platelet activation may have a deleterious role on aneurysm rupture. The assumption is that patients with ruptured intracranial aneurysm will present a higher rate of platelet activation compared to patients with non ruptured aneurysms.

NCT ID: NCT03400319 Completed - Clinical trials for Obstructive Sleep Apnea

Obstructive Sleep Apnoea in Adolescents With Thoracic Aortic Aneurysm

OSA in TAA
Start date: July 5, 2014
Phase:
Study type: Observational

The objective of this prospective cohort study is to determine the prevalence of obstructive sleep apnoea (OSA) in patients with and without thoracic aortic aneurysm.

NCT ID: NCT03399266 Recruiting - Clinical trials for Prelabor Rupture of Membranes

Balloon Induction of Labor in PROM for TOLAC

BILROM-TOLAC
Start date: March 1, 2018
Phase: N/A
Study type: Interventional

A prospective randomized controlled trial to evaluate the safety and efficacy of labor induction with a double balloon catheter (Atad Ripener Device) in women desiring TOLAC (trial of labor after cesarean) with PROM (pre labor rupture of membranes).

NCT ID: NCT03389685 Withdrawn - ACL Injury Clinical Trials

Can PRP Reduce Pro-Inflammatory Biomarkers Following ACL Injury

Start date: September 9, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this single-center, double-blinded randomized control trial with prospective data collection is to assess the ability of platelet rich plasma (PRP) treatment to reduce the level of pro-inflammatory synovial fluid biomarkers following an acute anterior cruciate ligament (ACL) tear. The study will collect and analyze synovial fluid of patients presenting with an acute anterior cruciate ligament (ACL) tear with a second synovial fluid sampling at the time of surgery. It will compare synovial fluid biomarker levels between those receiving an intra-articular Platelet Rich Plasma (PRP) injection versus an intra-articular saline injection serving as a control. Post-operative clinical outcomes will also be assessed, including post-operative pain levels, incidence of post-operative knee stiffness and patient reported outcome scores.

NCT ID: NCT03365908 Enrolling by invitation - Clinical trials for Anterior Cruciate Ligament Rupture

Pain Management of ACL Reconstruction

Start date: October 9, 2017
Phase: N/A
Study type: Interventional

This study will compare the outcome of pain interventions that are considered standard of care during the surgical treatment of ACL injuries. The comparison will be looking at pain control during and after ACL surgery as well as functional outcomes in patients that had a nerve block versus those who did not. The investigators hypothesize that pain control will be equal between both groups.

NCT ID: NCT03359382 Recruiting - ACL Injury Clinical Trials

The Rehabilitation Effect of Exercise Training in Cruciate Ligament Reconstruction Patients.

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

After anterior cruciate ligament (ACL) injury, the involved quadriceps may demonstrate weakness due to decrease in quadriceps activation. However, elapsed time from the injury may affect muscle strength by restoration of the quadriceps activation. The injury is characterized by joint instability that leads to decreased activity, unsatisfactory knee function, and poor knee-related quality of life in the short term, and it is associated with an increased risk of osteoarthritis on the knee. This study was designed to compare muscle strength, questionnaire and knee function in patients with different exercise training.

NCT ID: NCT03348995 Active, not recruiting - Clinical trials for Anterior Cruciate Ligament Rupture

The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration

Start date: April 17, 2018
Phase: N/A
Study type: Interventional

Bridge-Enhanced ACL Restoration (BEAR) is a new procedure being developed to treat patients with ACL injuries. In the BEAR procedure, an implant is placed between the torn ends of the ACL and the patient's own blood is added to the implant to stimulate ligament healing. We propose the current study to determine if older patients do better than younger patients (or vice versa) with this procedure. This is a cohort study designed to determine if age is a risk factor for a worse outcome after a bridge-enhanced ACL repair (BEAR) as defined by an 11.5 point difference on the IKDC Subjective or Objective Knee Evaluation score at two years after surgery. Additional objectives are to determine the effect of age on safety outcomes including infection, graft rejection, and need for further surgical procedures.

NCT ID: NCT03320408 Completed - Clinical trials for Abdominal Aortic Aneurysm

Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers

PARIS
Start date: October 4, 2017
Phase:
Study type: Observational [Patient Registry]

First aim: PARIS study The main aim of the current study is to determine the association between abdominal aortic aneurysm (AAA) progression and the evolution of proteases and cytokines levels.To achieve this aim, we will prospectively collect blood, aortic tissue, patient data, and imaging data. Aortic tissue will only be obtained when patients undergo conventional open repair. The other biomaterials will be collected during regular patient follow-up visits, with a maximum frequency of once per year. Second aim: Pearl AAA biobank For future research purposes, a new biobanking infrastructure will be created to collect and store additional blood and urine samples in a biobank. This biobank will be embedded within the infrastructure of the 'Parelsnoer Institute' (PSI) and will be called Pearl AAA. The Pearl AAA will be established in the extension of the PARIS study

NCT ID: NCT03312088 Recruiting - Infection Clinical Trials

Maxx Orthopedics' PCK Revision TKA Study of Component Survivorship

Start date: January 1, 2019
Phase:
Study type: Observational

The objectives of this clinical investigation are to evaluate the safety and performance of the Freedom Total Knee® PCK System.

NCT ID: NCT03310333 Recruiting - Clinical trials for PROM (Premature Rupture Of Foetal Membrane)

Cook Balloon Versus Propess After 12 Hours of Rupture of Membranes

RUBAPRO
Start date: February 14, 2018
Phase: Phase 4
Study type: Interventional

The objective is to demonstrate the superiority of the strategy of labor induction by Cook® cervical ripening balloon between recommended strategy by dinoprostone (propess®) on the reduction of the time between cervical ripening and delivery in case of unfavorable cervix after 12 hours of PROM in term pregnant women.